By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clarient, Inc. 

31 Columbia

Aliso Viejo  California  92656  U.S.A.
Phone: 949-425-5700 Fax: 949-425-5701


Company News
NeoGenomics (NGNM.OB) Reports 159% Revenue Growth To $59.7 Million And 442% Adjusted EBITDA Increase To $8.2 Million, Driven By Clarient Acquisition And Strong Volume Gains 4/27/2016 6:56:55 AM
NeoGenomics (NGNM.OB) Completes Acquisition Of Clarient 12/31/2015 6:12:05 AM
NeoGenomics (NGNM.OB) Bags GE Healthcare's Clarient in Cash-Stock Deal Worth $275 Million 10/21/2015 6:18:54 AM
Definiens Signs Agreement With Clarient, Inc. To Offer Validated Solutions For Routine Clinical Pathology Testing 2/3/2014 8:16:37 AM
bioMerieux, Inc.'s THxID®-BRAF Test For Detection Of 2 BRAF Mutations V600E And V600K In Late-Stage Metastatic Melanoma Adopted By Clarient, Inc., A GE Healthcare Company 1/29/2014 10:49:42 AM
Clarient, Inc., a GE Healthcare Company, Introduces First Lab Developed Test to Assess Multiple Proteins at Single-Cell Level 7/10/2013 9:25:30 AM
Arno Therapeutics to Collaborate With Clarient, Inc. for Development of Diagnostic Test 5/10/2013 9:33:45 AM
Clarient, Inc. and ACORN Research LLC Announce a Collaboration to Standardize Testing of Most Common Cancers 12/9/2011 6:38:30 AM
Clarient, Inc. Joins the HistoRx, Inc. Clinical Trials Network: First Commercial Lab to Provide Aqua(R) Technology for Clinical Trials 10/24/2011 2:18:16 PM
Biocept, Inc. and Clarient, Inc. Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients 8/25/2011 11:07:39 AM